Summary, Imaging and quantitative analysis of insulin-receptor interaction was studied in vivo in lean and obese Zucker rats, using a recently developed technique in which purified Tyr M4 123I-monoiodoinsulin is intravenously injected and the tracer followed by scintillation scanning. The obese rats were 72% overweight, had near normal blood glucose concentrations and an ll-fold increase in plasma insulin concentration. In both groups of rats, the tracer was rapidly taken up by the liver (by a receptor mediated mechanism) and the kidneys (by a non-receptor mediated process). Past this maximum, radioactivity decreased in both organs as 123I-insulin was degraded and free ~z3I-iodide was released into the plasma compartment. Heart radioactivity (i. e. blood pool) mirrored that of the liver and kidneys. The rapid initial decrease of blood radioactivity was concomitant with liver and kidney uptake of 123I-insulin. Release of free iodide from these organs induced a slow secondary rise of blood radioactivity followed by a final decline corresponding to clearance of plasma iodide, mainly by urinary excretion. Liver radioactivity profiles of lean and obese rats were parallel. When expressed per g weight, liver radioactivity was significantly decreased in obese rats. However, due to hepatomegaly in obese rats, total liver radioactivity was significantly higher in homozygous fa/fa rats than in lean littermates. Furthermore, if the marked hyperinsulinaemia of the obese rats is taken into account, total bound insulin was enhanced in the liver of fa/fa rats whatever reference is used, either g weight or total liver. The kidney profile of radioactivity of both rats was not significantly different. In conclusion: (1) obese rats are insulin resistant as near normal glycaemia is achieved at the price of a marked hyperinsulinaemia; (2) liver uptake of insulin is enhanced in obese rats, and (3) the insulin resistance syndrome of fa/fa rats is not due to a decrease in liver insulin receptor number and/or affinity but rather to as yet unknown event(s) subsequent to receptor binding.
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In 1961, Zucker and Zucker described a syndrome of obesity, hyperinsulinaemia and hyperlipaemia in rats, that is inherited as an autosomal recessive mutation [1] . In homozygous fa/fa rats, the syndrome becomes visible after weaning with hyperinsulinaemia being one of the earliest signs [2] . The affected rats are hyperphagic [3] , lose their normal pattern of nocturnal feeding [4] , rapidly accumulate fat mainly in their subcutaneous tissue and display a low level of spontaneous activity [5] . Pancreatic B cell hyperplasia and hypertrophy are present [6] and in vitro, islet tissue releases massive amounts of insulin [7, 8] . Together with adiposity and hyperinsulinaemia, a syndrome of insulin resistance appears. Insulin binding to isolated soleus muscle has been shown * Present address: Department of Internal Medicine, University of Liege, H6pital de Bavi6re, 66 Boulevard de la Constitution, B-4020 Liege, Belgium to be decreased [9] , while that to hepatocytes has been more variable with some studies indicating a decreased binding [10, 11] or mildly decreased binding [12] or no change [13] , especially when investigations were performed on young rats (10-15-week old). In the present study, we have applied a new technique involving 123I-labelled insulin and scintillation scanning [14] to study insulin kinetics and half-life in vivo in this animal model of obesity and insulin resistance.
Materials and methods
Twenty to 25 week-old lean (fa/-) and obese (fa/fa) female Zucker rats were obtained from Dr. M. Greenwood (Vassar College, Poughkeepsie, New York, USA). All had free access to a standard laboratory diet until the time of the experiment. The rats were anaesthetized with pentobarbital (60 mg/kg, IP) and a PE 50 polyethylene tube was introduced into a jugular vein.
Purified bovine insulin (0.1 mg) was labelled with 123I (5 mCi) and the species monoiodinated on Tyr A14 rapidly purified by high pressure liquid reverse phase chromatography using a technique described previously (theoretical spec. act. -= 41 mC//xg, assuming ~23I had 100% radiochemical purity and was totally cartier-free) [14] .
Rats were laid in the prone position on the converging collimator of a Large Field of View Scintillation camera (Searle, Des Plaines, Illinois, USA) connected to a Gamma 11 computer (Digital Equipment Corporation, Maynard, Massachusetts, USA). 123I-Insulin (30-60 gCi, based on theoretical spec. act., 0.73-1.46 ng) was injected IV as a bolus at time zero. Kinetic data were recorded in zoom mode, in a 64 x 64 matrix. Frame rate was one/5 s for the first 5 rain and one/30 s for the following 25 min. At the end of the 30-rain recording period, blood was drawn by heart puncture, the liver, kidneys and stomach were rapidly dissected, the weights of the liver and kidneys were measured and a static frame of the carcass and isolated liver, kidneys and stomach was taken.
Using a radioisotope calibrator (Capintec, Ramsey, New Jersey, USA), the actual injected radioactivity (~tCi) was measured by counting the activity of the a23I-insulin contained in the syringe before and after the IV injection. Using the static frame taken at minute30, the apparent radioactivity of the isolated kidneys, liver and stomach and of the remaining carcass (cpm) was measured and the sum of these values was taken as 100% of injected radioactivity. The respective percentages of radioactivity in the liver and kidneys at 30 rain were calculated.
A 3 x 3 cells region of interest was defined over the right upper part of the liver. This location was selected to eliminate the influence of radioactivity in the aorta and vena cava on the one hand, and of the right kidney on the other hand. After subtraction of background taken over the hip, the liver time-activity curve was obtained and calibrated by using the actual percentage of radioactivity in the liver at 30 rain.
A 4 x 2 cells region of interest was similarly defined over the lower pole of each kidney. This location was selected to minimize the influence of partially superimposed organs, mainly the liver and stomach. After subtraction of background taken under the lower pole of each kidney, a time-activity curve was obtained and its ordinate calibrated by using the actual percentage of radioactivity in the kidneys at 30 rain.
A 4 x 2 cells region of interest was also defined over the heart and the time-activity curve of this region was taken as representative of blood radioactivity.
Blood glucose and plasma immunoreactive insulin measurements were kindly performed by Dr. Soeldner (EP Joslin Diabetes Center, Boston, Mass) using the glucose oxidase method and the double-antibody immunoprecipitation method with a porcine insulin standard. 
Results are expressed as mean + SD with number of observations in parentheses
Statistical analysis
The BMD P2V program of analysis of variance of repeated measures was employed to test the difference between two groups and the interaction between groups and time [15] . When analyzing liver data, a first run of the program showed a high correlation between cell means and standard deviations. Log transformation of the data reduced this correlation to 0.0477 and 0.0910 respectively, when liver radioactivity was expressed per g weight of tissue or per whole organ. Having satisfied the criteria of homoskedasticity, a standard Snedecor test was applied.
In the case of the kidneys, even after log transformation, a weak correlation still existed between the mean of the log of the variables and their standard deviation (r= 0.41). The Huynh-Feldt test was applied [16] with decreased number of degrees of freedom.
The Student's t-test also was used to compare unpaired data.
Results
The biological characteristics of the animals studied are summarised in Table 1 . The body weight of the obese animals was 72% above that of lean littermates. In obese rats, liver weight was doubled and kidney weight was increased by 30%. The average blood glucose concentration was higher in obese animals, but the difference was not statistically significant. By contrast, the fa/ fa rats were markedly hyperinsulinaemic, consistent with an insulin resistant state. Their plasma had a milky appearance, due to hyperlipaemia and particularly to the well known increase in very low density lipoproteins [171.
For each pair of rats studied, sequential scintigraphic images were taken at 3, 10, 20 and 30 min and an example of such images is shown in Figure 1 . Early images (3 and 10min) were essentially the same for each of the studied pairs and for both types of rats. They indicate early uptake of 123I-insulin by the liver and kidney (Fig. 1 a) followed by a decrease of radioactivity in both organs as 123I-insulin is degraded and free 123I-iodide is released into the plasma. Late images essentially reflect free iodide biodistribution ( Fig. 1 c and d) . The pair illustrated in Figure 1 was selected because it best illustrates a difference of free iodide biodistribution between lean and obese animals. Indeed, in this example, the bladder of the lean rat is already visible after 20 min, whereas that of the obese rat is still not detectable after 30 min. In the lean rat, despite urinary iodide loss, the stomach is much more radioactive than that of the obese littermate. As we have shown previously, receptor-mediated uptake can be estimated using this technique by following liver radioactivity [14, 181. The log of liver radioactivity (percentage of total injected) was expressed either per whole organ (Fig. 2a) or per g weight of tissue  (Fig.2b) . In both lean and obese animals, hepatic uptake was rapid, reaching a maximum between 3 and 4 min. When expressed per g of liver, the time-activity curve for the obese animals was parallel (F=1.17; p= 0.1855) and significantly lower than that of the lean rats (F=10.06; p=0.0089). On average, the uptake of insulin by liver of obese rats was reduced 40% when expressed per g of tissue. By contrast, when radioactivity profiles of whole liver were compared, the time-activity curves remained parallel (F=1.20; p=0.1532) but the curve of the obese animal was higher (F=19.66; p=0.001). This is a reflection of the massive hepatomegaly present in the obese rats.
The kidney uptake of 123I-insulin was slower than hepatic uptake, reaching a maximum at 10min (Fig. 2 d) . In obese rats, kidney uptake was slightly higher than that in lean rats. However, the two curves were not statistically different (F--1; p= 0.3397) and using the Huynh test, there was no interaction with time (F= 1.70; p= 0.1544).
Heart (i. e. blood) radioactivity profile of obese and lean rats is shown in Figure 2 c. Initial decrease of blood radioactivity during the first 3 min was quite comparable in both types of rats. Blood radioactivity reached a minimum at 3 min in control rats, and this was followed by an increase as radioactivity re-entered the plasma compartment as free iodide. This secondary rise of plasma radioactivity was delayed and less marked in the obese rats.
Gastric radioactivity at 30min was 10.95+2.75% (mean+SD) of the total injected in lean rats and 6.94 + 1.94% in obese animals. The difference was statistically different (p < 0.05).
Discussion
Over the past 10 years, it has become clear that in a variety of insulin resistant states, there is an alteration in the insulin-receptor interaction as measured using techniques in vitro and cells taken from the animal. Recently, we have described a new technique which allows us to study the insulin-receptor interaction and the fate of insulin in intact animals. This technique depends on labelling insulin with 123I to a very high specific activity (theoretical value 41 mCi/Ixg) and following the labelled insulin by using a scintillation scanner. In previous studies, we showed that the most prominent uptake occurred by the liver, which reached a maximum in 3-4 min and was about 30% of the total injected dose. This uptake appears to be receptor-mediated and can be blocked by injection of excess unlabelled insulin [14] or by antibodies to the insulin receptor [18] . Renal uptake represented about 15% of the total injected dose, but did not appear to be receptor mediated, and actually increased when hepatic uptake was blocked by insulin or anti-receptor antibody [14, 18] . In the present study, we have applied this technique to study insulin biokinetics and receptor interaction in the Zucker obese rat.
We have found that insulin biokinetics in the Zucker fatty rat is, in general, similar to that in its lean littermate. There appears to be a difference in 123I-insulin uptake by liver of the obese rat, but the difference depends on whether binding is expressed per g weight of liver or per whole liver. In the former case, maximum liver radioactivity in obese rats was decreased by 30%, whereas in the latter case, it was increased by 36% in obese rats compared with thin littermates. Thus, while there seems to be a modest decrease in 123I-insulin uptake per g of tissue in this model of obesity, this is more than compensated for by the increase in liver size in the obese rats. Furthermore, the decrease in t23I-insulin uptake is also compensated for by endogenous hyperinsulinaemia. If peripheral plasma IRI is taken into account, the liver of obese Zucker rats has a great deal more insulin bound, whatever reference is used. Indeed, at 3 min, the ratio of total insulin bound per g of liver of obese to lean rat percent of radioactivity per g of obese liver x plasma I RI concentration in obese rats/ percent of radioactivity per g of lean liver x plasma IRI concentration in lean rats J was 7.6 whereas, when uptake was expressed per whole liver, the ratio was 13.6. These ratios should be taken as indicative only, as we did not verify that the ratios of plasma IRI concentration in obese and lean rats were the same in portal as in peripheral plasma. In addition, because insulin half life in the liver was the same in both animals, the overall flux of insulin through the hepatocyte of obese animals was markedly enhanced. This conclusion that hepatic flux of insulin is markedly increased in obesity is not in contradiction with in vitro observations that insulin receptor number is normal or slightly decreased. Firstly, total receptor number as defined by Ro in the Scatchard plot is much greater than the number of receptors occupied in the presence of physiological insulin concentration. As a consequence, bound insulin markedly increases if cells or membranes are exposed to an insulin concentration which is 1 l-fold higher than the physiological one. Thus, also in vitro, even if there was a modest decrease in Ro, cells or membranes isolated from obese rats and exposed to insulin concentrations usually achieved in fa/fa rats would bind more insulin than their lean counterpart exposed to lean rat insulin concentration. Secondly, in vivo, hepatic insulin flux depends upon other factors than Ro and Kd, among which is hormone delivery to the liver, i.e. hepatic blood flow. We have observed previously in normal rats that there is an inverse relationship between hepatic and renal insulin uptake. In the obese Zucker rat, kidney uptake of 123I-insulin was slightly, but not significantly, increased; this is similar to the effect of an injection of a small amount of anti-insulin receptor antibody [18] and suggests that more insulin is available to the kidney, possibly reflecting a decrease in the functional extrahepatic receptor compartment or its partial saturation by the high plasma insulin levels. Taking into account the high plasma IRI in the obese rats, the overall amount of insulin retained by the kidneys was 11-fold higher in obese rats than in lean littermates. This observation is consistent with that of Eng and Yalow who found more radioimmuno-assayable insulin in the kidneys of obese mice [19] .
It is now believed that plasma insulin clearance rate partly reflects the size of the receptor compartment [20] [21] [22] . In the present study, the initial rate of decrease of plasma radioactivity was at least as high in obese rats as in lean littermates. The two plasma radioactivity curves become divergent after the third minute, a time at which free 123I-iodide appears in the plasma and later becomes the prominent radioactive species [21] . Between 10 and 30 min, plasma t23I-iodide concentration was significantly lower in obese rats. Inspection of Figure 2 a and d indicates that the release of radioactivity by the liver and kidney is not retarded in obese rats. Less t23I-was accumulated by the stomach and excreted in the urine (Fig. 1 d) . Other authors have shown that iodide uptake was also decreased in the thyroid gland [23] . From the above considerations, the most likely explanation is that t23I-iodide distribution volume was larger in obese than in lean rats.
In conclusion, the obese Zucker fatty rat is insulin resistant as near normal glycaemia is achieved at the price of an 11-fold increase in plasma IRI concentration. This high plasma IRI concentration reflects an increased insulin flux as more hormone is produced by the pancreatic B cells and more is taken up and degraded by the liver and kidney. In the obese mutant, insulin resistance is not due to a decrease in liver insulin receptors, but rather to a yet unknown abnormality of post-receptor binding events. Whether conclusions reached with this animal model must be restricted to it or are also applicable to other types of obesity and particularly in man remains to be determined.
